United States Eleventh Circuit

Claims under section 11 of the Securities Act of 1933 were properly dismissed where defendant had no duty to disclose relevant prescription data in a prospectus, and representations about a drug were not misleading; award of fees and was proper based on deliberate indifference to the lack of factual support for claims asserted.

Appellate Information

• Decided 07/16/2002
• Published 07/16/2002

Judges

• GARWOOD, Circuit Judge:, Before EDMONDSON, Chief Judge, and FAY and GARWOOD, Circuit Judges.

Court

• United States Eleventh Circuit

Counsel

• For Appellant:
  
• Ricardo A. Banciella, Miami, FL, Atlee W. Wampler, III., Wampler, Buchanan & Breen, P.A., Miami, FL, Arthur T. Susman, Chicago, IL, for Plaintiff-Appellant in No. 99-11690., Robert E. Williams, Arthur T. Susman, Susman & Watkins, Chicago, IL, Charles R. Watkins, Chicago, IL, for Plaintiffs-Appellants in No. 00-13220.


• For Appellees:
  
• Linda Collins Hertz, Tracy A. Nichols, Louise M. Brais, Holland & Knight, LLP, Miami, FL, for Defendants-Appellees in No. 99-11690., Louise M. Brais, Tracy Nichols, Holland & Knight, Miami, FL, Gerald J. Houlihan, Houlihan and Partners, P.A., Miami, FL, for Defendants-Appellees in No. 00-13220.